FWM
ORMP icon

Frontier Wealth Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Frontier Wealth Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-72,600
Closed -$971K – 443
2021
Q2 		$971K Hold
72,600
– – 0.07% 185
2021
Q1 		$738K Buy
72,600
+700
+1% +$5.75K 0.06% 202
2020
Q4 		$305K Hold
71,900
– – 0.03% 291
2020
Q3 		$188K Hold
71,900
– – 0.02% 342
2020
Q2 		$254K Hold
71,900
– – 0.02% 297
2020
Q1 		$219K Buy
+71,900
New +$315K 0.04% 257

Other funds holding ORMP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return
JC
Jetstream Capital Brentwood, Tennessee $1.37M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return